Presentation is loading. Please wait.

Presentation is loading. Please wait.

ANZDATA Registry Annual Report 2013 Philip Clayton CHAPTER 9 KIDNEY DONATION 2013 Annual Report - 36th Edition PAEDIATRIC CHAPTER 11.

Published byMaurice Webb Modified over 8 years ago

Similar presentations

Presentation on theme: "ANZDATA Registry Annual Report 2013 Philip Clayton CHAPTER 9 KIDNEY DONATION 2013 Annual Report - 36th Edition PAEDIATRIC CHAPTER 11."— Presentation transcript:

1 ANZDATA Registry Annual Report 2013 Philip Clayton CHAPTER 9 KIDNEY DONATION 2013 Annual Report - 36th Edition PAEDIATRIC CHAPTER 11

2 ANZDATA Registry Annual Report 2013 Figure 11.1a

3 ANZDATA Registry Annual Report 2013 Figure 11.1b

4 ANZDATA Registry Annual Report 2013 Figure 11.2a

5 ANZDATA Registry Annual Report 2013 Figure 11.2b

6 ANZDATA Registry Annual Report 2013 Figure 11.3 Causes of End Stage Kidney Disease In Children and Adolescents 2007 - 2012 Australia and New Zealand Age Groups (Years) Total 0-45-910-1415-17 GN10 (12%)20 (31%)27 (33%)40 (40%)97 (29%) Familial GN2 (2%)3 (3%)5 (2%) Reflux Nephropathy4 (5%)2 (3%)5 (6%)10 (10%)21 (6%) Polycystic Kidney Disease8 (10%)5 (8%)1 (1%)2 (2%)16 (5%) Medullary Cystic Disease1 (2%)4 (5%)2 (2%)7 (2%) Posterior Urethral Valve7 (9%)11 (13%)2 (2%)20 (6%) Haemolytic Uraemic Syndrome 7 (9%)1 (2%)2 (2%) 12 (4%) Hypoplasia/Dysplasia24 (29%)14 (22%)10 (12%)14 (14%)62 (19%) Diabetes1 (1%)1 (0%) Cortical Necrosis2 (2%)2 (3%)2 (2%)3 (3%)9 (3%) Interstitial Nephritis1 (2%)1 (1%) 3 (1%) Cystinosis1 (2%)1 (1%)2 (1%) Uncertain1 (1%)2 (3%)5 (5%)8 (2%) Misc/Other19 (23%)16 (25%)16 (19%)16 (16%)67 (20%) Total826583100330

7 ANZDATA Registry Annual Report 2013 Figure 11.4 Modality of Initial Renal Replacement Therapy By Year of First Treatment - Australia and New Zealand < 18 Years of Age at First Treatment Current Treatment Year 200720082009201020112012Total 0-9 Years202327222926147 HD 4 (20%)6 (26%)4 (15%)5 (23%)10 (34%)8 (31%)37 (25%) PD 14 (70%)15 (65%)17 (63%)14 (64%)14 (48%)12 (46%)86 (59%) Transplant 2 (10%)2 (9%)6 (22%)3 (14%)5 (17%)6 (23%)24 (16%) 10-17 Years 313827252438183 HD 12 (39%)22 (58%)12 (44%)13 (52%)8 (33%)16 (42%)83 (45%) PD 12 (39%)8 (21%)12 (44%)5 (20%)10 (42%)15 (39%)62 (34%) Transplant 7 (23%)8 (21%)3 (11%)7 (28%)6 (25%)7 (18%)38 (21%) Total 516154475364330

8 ANZDATA Registry Annual Report 2013 Figure 11.5 Modality of Treatment for all Patients in Australia and New Zealand < 18 Years of Age at 31st December Current Treatment Year 200720082009201020112012Total Haemodialysis 24 (8%)35 (11%)29 (9%)30 (9%)29 (9%)30 (8%)177 (9%) Peritoneal Dialysis 55 (18%)54 (17%)57 (18%)50 (15%)52 (16%)49 (14%)317 (16%) Transplant 229 (74%)225 (72%)229 (73%)245 (75%)251 (76%)275 (78%)1454 (75%) Total 3083143153253323541948

9 ANZDATA Registry Annual Report 2013 Figure 11.6

10 ANZDATA Registry Annual Report 2013 Figure 11.7

11 ANZDATA Registry Annual Report 2013 Figure 11.8a

12 ANZDATA Registry Annual Report 2013 Figure 11.8b

13 ANZDATA Registry Annual Report 2013 Figure 11.9

14 ANZDATA Registry Annual Report 2013 Figure 11.10a

15 ANZDATA Registry Annual Report 2013 Figure 11.10b

16 ANZDATA Registry Annual Report 2013 Figure 11.11a

17 ANZDATA Registry Annual Report 2013 Figure 11.11b

18 ANZDATA Registry Annual Report 2013 Figure 11.12

19 ANZDATA Registry Annual Report 2013 Figure 11.13

20 ANZDATA Registry Annual Report 2013 Figure 11.14 Proportion of Prevalent Patients for whom URR or Kt/V was reported < 18 Years of Age at 31st December in Australia and New Zealand 2008 - 2012 Current Treatment Year Modality20082009201020112012 AustraliaHaemodialysis56%96% 63%61% AustraliaPeritoneal Dialysis13%7%10%5%10% New ZealandHaemodialysis80%100% 80%86% New ZealandPeritoneal Dialysis94%93%90%100%80%

21 ANZDATA Registry Annual Report 2013 Figure 11.15a

22 ANZDATA Registry Annual Report 2013 Figure 11.15b

23 ANZDATA Registry Annual Report 2013 Figure 11.16a

24 ANZDATA Registry Annual Report 2013 Figure 11.16b

25 ANZDATA Registry Annual Report 2013 Figure 11.17a

26 ANZDATA Registry Annual Report 2013 Figure 11.17b

27 ANZDATA Registry Annual Report 2013 Figure 11.18a

28 ANZDATA Registry Annual Report 2013 Figure 11.18b

29 ANZDATA Registry Annual Report 2013 Figure 11.19

30 ANZDATA Registry Annual Report 2013 Figure 11.20

31 ANZDATA Registry Annual Report 2013 Figure 11.19

32 ANZDATA Registry Annual Report 2013 Figure 11.21

33 ANZDATA Registry Annual Report 2013 Figure 11.22 Use of PD Solutions 2009 - 2012 Solutions Australia New Zealand 2009201020112012 2009201020112012 (n = 43)(n = 40) (n = 39)(n = 14)(n = 10)(n = 12)(n = 10)(n = 43) Glucose 42 (98%)30 (75%)28 (70%)35 (90%)14 (100%)10 (100%)12 (100%)10 (100%)42 (98%) Icodextrin 2 (5%) 6 (15%)9 (23%)1 (7%)0 (0%)2 (17%)3 (30%)2 (5%) Low GDP Lactate 11 (26%)17 (43%)11 (28%)5 (13%)12 (86%)8 (80%)10 (83%)5 (50%)11 (26%) Low GDP Bicarbonate 1 (2%)8 (20%)6 (15%)4 (10%)0 (0%) 1 (2%)

34 ANZDATA Registry Annual Report 2013 Figure 11.24

35 ANZDATA Registry Annual Report 2013 Figure 11.25

Download ppt "ANZDATA Registry Annual Report 2013 Philip Clayton CHAPTER 9 KIDNEY DONATION 2013 Annual Report - 36th Edition PAEDIATRIC CHAPTER 11."

Similar presentations

Chapter 7: Pediatric ESRD 2014 A NNUAL D ATA R EPORT V OLUME 2: E ND -S TAGE R ENAL D ISEASE.

Chapter 7: Pediatric ESRD 2014 A NNUAL D ATA R EPORT V OLUME 2: E ND -S TAGE R ENAL D ISEASE.
ANZDATA Registry Annual Report 2013 STOCK AND FLOW CHAPTER 1.

ANZDATA Registry Annual Report 2013 STOCK AND FLOW CHAPTER 1.
UK Renal Registry 16th Annual Report Figure 14.1. Data completeness for key variables, stratified by first modality HD = haemodialysis; PD = peritoneal.

UK Renal Registry 16th Annual Report Figure Data completeness for key variables, stratified by first modality HD = haemodialysis; PD = peritoneal.
UK Renal Registry 17th Annual Report Figure 10.1. Data completeness for key variables, stratified by first modality DOB = date of birth; PRD = primary.

UK Renal Registry 17th Annual Report Figure Data completeness for key variables, stratified by first modality DOB = date of birth; PRD = primary.
© ANZDATA Registry CANCER CHAPTER CHAPTER 10. © ANZDATA Registry CharacteristicMyelomaNon-Myeloma n%n% Total (%)807153,37199 Country of residence Australia6908644,25683.

© ANZDATA Registry CANCER CHAPTER CHAPTER 10. © ANZDATA Registry CharacteristicMyelomaNon-Myeloma n%n% Total (%)807153,37199 Country of residence Australia ,25683.
End Stage Kidney Disease Treatment Modalities Australia New Zealand Dec 2012 Prepared by Debbie Fortnum Kidney Health Australia Data courtesy of ANZDATA.

End Stage Kidney Disease Treatment Modalities Australia New Zealand Dec 2012 Prepared by Debbie Fortnum Kidney Health Australia Data courtesy of ANZDATA.
ANZDATA Registry Annual Report 2013 Philip Clayton CHAPTER 9 KIDNEY DONATION 2013 Annual Report - 36th Edition TRANSPLANT WAITING LIST CHAPTER 7.

ANZDATA Registry Annual Report 2013 Philip Clayton CHAPTER 9 KIDNEY DONATION 2013 Annual Report - 36th Edition TRANSPLANT WAITING LIST CHAPTER 7.
HAEMODIALYSIS CHAPTER 5. © ANZDATA Registry Figure 5.1 Stock and Flow of Haemodialysis Patients 2006 - 2010 20062007200820092010 Australia Patients new.

HAEMODIALYSIS CHAPTER 5. © ANZDATA Registry Figure 5.1 Stock and Flow of Haemodialysis Patients Australia Patients new.
Nancy Briggs Kylie Hurst Stephen McDonald CHAPTER 4 METHOD AND LOCATION OF DIALYSIS 2012 Annual Report—35th Edition ANZDATA Registry Annual Report 2012.

Nancy Briggs Kylie Hurst Stephen McDonald CHAPTER 4 METHOD AND LOCATION OF DIALYSIS 2012 Annual Report—35th Edition ANZDATA Registry Annual Report 2012.
UK Renal Registry 17th Annual Report Figure 9.1. Median height z-scores for transplant patients

UK Renal Registry 17th Annual Report Figure 9.1. Median height z-scores for transplant patients
UK Renal Registry 16th Annual Report Figure 10.1. Median haemoglobin for incident dialysis patients at start of dialysis treatment in 2012.

UK Renal Registry 16th Annual Report Figure Median haemoglobin for incident dialysis patients at start of dialysis treatment in 2012.
UK Renal Registry 14th Annual Report Figure 8.1. Median haemoglobin for incident dialysis patients at start of dialysis treatment in 2010.

UK Renal Registry 14th Annual Report Figure 8.1. Median haemoglobin for incident dialysis patients at start of dialysis treatment in 2010.
UK Renal Registry 17th Annual Report Figure 8.1. Percentage of haemodialysis patients with phosphate within the range specified by the RA clinical audit.

UK Renal Registry 17th Annual Report Figure 8.1. Percentage of haemodialysis patients with phosphate within the range specified by the RA clinical audit.
End Stage Kidney Disease among Indigenous Peoples of Australia and New Zealand ANZDATA Registry Annual Report 2014 - Chapter 12.

End Stage Kidney Disease among Indigenous Peoples of Australia and New Zealand ANZDATA Registry Annual Report Chapter 12.
Rowan Walker – Chairman 2000 -2007. Chair: Steve Chadban ANZDATA update (Stephen McDonald) Analgaesic nephropathy – the end of an epidemic? (Sean Chang)

Rowan Walker – Chairman Chair: Steve Chadban ANZDATA update (Stephen McDonald) Analgaesic nephropathy – the end of an epidemic? (Sean Chang)
NEW PATIENTS COMMENCING TREATMENTS IN 2010 CHAPTER 2.

NEW PATIENTS COMMENCING TREATMENTS IN 2010 CHAPTER 2.
ANZDATA Registry Annual Report 2013 NEW PATIENTS CHAPTER 2.

ANZDATA Registry Annual Report 2013 NEW PATIENTS CHAPTER 2.
© ANZDATA Registry Method and Location of Dialysis 1453 (30%) 632 (13%) 1317 (27%) 1335 (27%) Number of Patients Australia 31-Dec-96.

© ANZDATA Registry Method and Location of Dialysis 1453 (30%) 632 (13%) 1317 (27%) 1335 (27%) Number of Patients Australia 31-Dec-96.
ANZDATA Registry Annual Report 2013 Philip Clayton CHAPTER 9 KIDNEY DONATION 2013 Annual Report - 36th Edition PERITONEAL DIALYSIS CHAPTER 6.

ANZDATA Registry Annual Report 2013 Philip Clayton CHAPTER 9 KIDNEY DONATION 2013 Annual Report - 36th Edition PERITONEAL DIALYSIS CHAPTER 6.
Blair Grace Kylie Hurst Stephen McDonald CHAPTER 2 NEW PATIENTS COMMENCING TREATMENT IN 2011 2012 Annual Report—35th Edition ANZDATA Registry Annual Report.

Blair Grace Kylie Hurst Stephen McDonald CHAPTER 2 NEW PATIENTS COMMENCING TREATMENT IN Annual Report—35th Edition ANZDATA Registry Annual Report.

Similar presentations

Ads by Google